IL101675A - Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors - Google Patents
Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptorsInfo
- Publication number
- IL101675A IL101675A IL101675A IL10167592A IL101675A IL 101675 A IL101675 A IL 101675A IL 101675 A IL101675 A IL 101675A IL 10167592 A IL10167592 A IL 10167592A IL 101675 A IL101675 A IL 101675A
- Authority
- IL
- Israel
- Prior art keywords
- neurokinine
- receptors
- detecting
- pharmaceutical compositions
- localizing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91200955 | 1991-04-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL101675A0 IL101675A0 (en) | 1992-12-30 |
IL101675A true IL101675A (en) | 1997-11-20 |
Family
ID=8207620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL101675A IL101675A (en) | 1991-04-22 | 1992-04-22 | Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0584256B1 (xx) |
JP (1) | JPH06507174A (xx) |
AT (1) | ATE186550T1 (xx) |
AU (1) | AU2175492A (xx) |
CA (1) | CA2106874A1 (xx) |
DE (1) | DE69230287T2 (xx) |
IL (1) | IL101675A (xx) |
WO (1) | WO1992018536A2 (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9401483D0 (en) * | 1994-01-26 | 1994-03-23 | Sandoz Ltd | Organic compounds |
US20010023288A1 (en) * | 1999-07-07 | 2001-09-20 | Wilbur D. Scott | Trifunctional reagent for conjugation to a biomolecule |
CA2190679A1 (en) * | 1996-11-19 | 1998-05-19 | Christopher J. Paige | Lymphocyte tachykinin |
US6106804A (en) * | 1997-06-13 | 2000-08-22 | The University Of New Mexico | Arsenic-72 labeled compounds for tissue specific medical imaging |
US20030032599A1 (en) * | 2000-11-21 | 2003-02-13 | Lipkowski Andrzej W. | Novel antimicrobial compounds |
ES2246687B2 (es) * | 2004-02-11 | 2006-11-16 | Miguel Muñoz Saez | Utilizacion de antagonistas no peptidicos de receptores nk1 para la produccion de apoptosis en celulas tumorales. |
WO2016025322A1 (en) * | 2014-08-09 | 2016-02-18 | Purdue Research Foundation | Design and development of neurokinin-1 receptor-binding agent delivery conjugates |
EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
WO2018096082A1 (en) | 2016-11-28 | 2018-05-31 | Bayer Pharma Aktiengesellschaft | High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging |
MX2021006024A (es) | 2018-11-23 | 2021-07-06 | Bayer Ag | Formulacion de medios de contraste y proceso para prepararlos. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4481139A (en) * | 1983-04-13 | 1984-11-06 | Board Of Regents, The University Of Texas System | Peptide antagonists of substance P |
US4942231A (en) * | 1984-05-24 | 1990-07-17 | Mallinckrodt, Inc. | Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound |
EP0176436A3 (en) * | 1984-09-26 | 1987-12-16 | Merck & Co. Inc. | Analogs of substance p and eledoisin |
GB8613431D0 (en) * | 1986-06-03 | 1986-07-09 | Medical Res Council | Human tachykinins |
EP0401302B1 (en) * | 1988-02-09 | 1995-06-28 | Mallinckrodt, Inc. | Method of preparing a metal-radionuclide-labelled protein |
NZ229552A (en) * | 1988-06-20 | 1992-06-25 | Merrell Dow Pharma | Neurokinin a antagonists |
-
1992
- 1992-04-22 AT AT92912903T patent/ATE186550T1/de not_active IP Right Cessation
- 1992-04-22 JP JP4511766A patent/JPH06507174A/ja active Pending
- 1992-04-22 WO PCT/US1992/003307 patent/WO1992018536A2/en active IP Right Grant
- 1992-04-22 CA CA002106874A patent/CA2106874A1/en not_active Abandoned
- 1992-04-22 DE DE69230287T patent/DE69230287T2/de not_active Expired - Fee Related
- 1992-04-22 AU AU21754/92A patent/AU2175492A/en not_active Abandoned
- 1992-04-22 IL IL101675A patent/IL101675A/xx not_active IP Right Cessation
- 1992-04-22 EP EP92912903A patent/EP0584256B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1992018536A2 (en) | 1992-10-29 |
AU2175492A (en) | 1992-11-17 |
DE69230287D1 (de) | 1999-12-16 |
IL101675A0 (en) | 1992-12-30 |
EP0584256B1 (en) | 1999-11-10 |
ATE186550T1 (de) | 1999-11-15 |
DE69230287T2 (de) | 2000-05-11 |
WO1992018536A3 (en) | 1992-11-26 |
JPH06507174A (ja) | 1994-08-11 |
CA2106874A1 (en) | 1992-10-29 |
EP0584256A1 (en) | 1994-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
TW250435B (xx) | ||
DE69010336D1 (de) | Pharmazeutische zusammensetzung zum abnehmen. | |
MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
IL101675A (en) | Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors | |
BR9813318A (pt) | Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário | |
EP0981360A4 (en) | METHOD FOR PREVENTING GASTRITIS USED BY AMYLIN OR AMYLIN AGONISTS | |
EP1006793A4 (en) | COMPOSITIONS FOR TREATING ARRHYTHMIA AND METHODS OF TREATMENT | |
PT1076561E (pt) | Terapia de combinacao para o tratamento de tumores | |
ZA972601B (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
WO1999011256A8 (fr) | L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme | |
DE3462688D1 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
DK0406216T3 (da) | Protein-S-holdigt farmaceutisk præparat | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
MX9303074A (es) | Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer. | |
IL126158A0 (en) | Method for treating substance abuse | |
DE3473826D1 (en) | N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor | |
AU3577889A (en) | Method of localizing and quantifying regional energy metabolism in a warm-blooded living being and composition therefor | |
BR9713828A (pt) | Tratamento de tumores altamente vasculares | |
GB2013210A (en) | Therapeutically Useful Pseudopeptides, Compositions Containing the Same and Methods of Preparation and Use | |
IT1264562B1 (it) | Composizione farmaceutica per l'applicazione topica di 17,b estradiolo nel trattamento della cheratocongiuntivite sicca | |
DK0427633T3 (da) | Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |